California presses DRUG RE-IMPORTATION, pricing measures

Bloice, Carl
May 2004
Revolution: The Journal for RNs & Patient Advocacy;May/Jun2004, Vol. 5 Issue 3, p8
The article reports that the State Senate and State Assembly of California passed a variety of bill in May 2004, which would facilitate importing medications, allow state government agencies to buy drugs in bulk from Canada and monitor the safety of imports. According to California Nurses Association President Deborah Burger, the legislation is a welcome step forward and will encourage the growing national movement to confront the out of control pharmaceutical industry. The state spends about $1.5 billion a year on drugs for medical patients.


Related Articles

  • The thornier side of PDMA. O'Rourke, Peg // Medical Marketing & Media;Mar2008, Vol. 43 Issue 3, p78 

    The author reflects on the problems related to drug distributing system, resulting from the implementation of Prescription Drug Marketing Act (PDMA) in the U.S. She assesses that PDMA faces problems such as breaches within the distribution system leading to counterfeiting and diversion among...

  • WASHINGTON INSIDER: Update.  // Medical Marketing & Media;Sep2008, Vol. 43 Issue 9, p18 

    The article offers news briefs related to pharmaceutical industry in the U.S. Former Food and Drug Administration chief counsel Dan Troy was hired by GlaxoSmithKline as its new general counsel. Representatives Frank Pallone and Henry Waxman have introduced a legislation to reverse the decision...

  • PhRMA Critical of Drug Importation Bill. Hess, Glenn // Chemical Market Reporter;8/4/2003, Vol. 264 Issue 3, p4 

    Reports on the legislation passed by the U.S. Congress which is opposed by the pharmaceutical industry in the U.S. Provision of the bill; Implications of the bill on drugmakers and manufacturers; Specification of the legislation.

  • How the Indian pharmaceutical sector is reinventing itself. Valentin, Gilles; Berthemet, Emmanuelle // Pharmaceutical Technology;Sep2007, Vol. 31 Issue 9, p67 

    The article discusses how pharmaceutical industry began in India. In the 1970s, India had hardly any noticeable activity that could have accounted for being part of a domestic pharmaceutical industry. With the implementation of the 1970 Patents Act, the country began building chemical know-how...

  • THE PROBLEM WITH DRUG REIMPORTATION. Pitts, Peter // Saturday Evening Post;Mar/Apr2005, Vol. 277 Issue 2, p80 

    Discusses the issues surrounding drug importation in the U.S. as of April 2005. History of drug laws in the country; Appeal of drug imports to consumers; Dangers linked with drug imports.


    Reports on a patent infringement lawsuit filed by several drug companies against the South African government concerning a law passed by parliament that allows HIV drugs to be imported from countries where they are produced generically. Estimated number of South Africans infected with HIV;...

  • Drug import bill drawing support of U.S. House.  // Indianapolis Business Journal;5/30/2005, Vol. 26 Issue 12, p20 

    Reports on the growing support for the Drug Import Bill, which would allow Americans to buy cheaper medicines from other countries, in the U.S. House of Representatives. Appeal of Representative Gil Gutknecht to quicken the passage of the bill; Assertion that Americans buy prescription drugs...

  • Drug Product Selection: The Florida Experience. Vuturo, George J.; Krischer, Jeffrey P.; McCormick, William C. // American Journal of Public Health;May80, Vol. 70 Issue 5, p479 

    Abstract: Drug product selection, the act of selecting and dispensing a lower cost generically equivalent product to that prescribed, is made possible in 46 states through recently enacted legislation. Florida's legislation is unique in that it requires pharmacists to product select under...

  • Advocates raise alarm over biodefense patent extensions. Frederick, Jim // Drug Store News;11/12/2007, Vol. 29 Issue 14, p36 

    The article reports on the appeal of the Coalition for a Competitive Pharmaceutical Market (CCPM) to the U.S. Senate to disapprove the provisions included in the abridgements legislation. Bill 1873 will extend drug monopolies for brand-name drug manufacturers. CCPM members argue that the bill,...

  • New laws could alter U.S. import rules.  // World Trade;Apr2008, Vol. 21 Issue 4, p12 

    The article reports that the Canadian pharmaceutical industry is worried that the next U.S. president will pass the Dorgan-Snowe bill. It is raising concerns about an outflow of medicine that could threaten drug supply in Canada. Under the pending bill, U.S. wholesalers, pharmacies and...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics